期刊文献+

急性白血病化疗后不同时期应用粒细胞集落刺激因子的疗效比较 被引量:8

Effects comparison of G-csf applied in different periods of acute leukemia after chemotherapy
暂未订购
导出
摘要 目的观察急性白血病(AL)化疗后不同时期应用粒细胞集落刺激因子G-CSF的疗效。方法随机选择处于缓解期的急性白血病30例,分为2组,分别在化疗后48 h(治疗组)和中性粒细胞(ANC)<1.0×109/L(对照组)使用粒细胞集落刺激因子,当ANC≥1.5×109/L时停药。观察ANC变化及感染发生率。结果治疗组ANC≤0.5×109/L持续天数,ANC≥1.5×109/L所需天数,使用粒细胞集落刺激因子天数,感染发生率均明显小于对照组(P<0.05),ANC最低值明显高于对照组(P<0.05)。结论急性白血病在化疗后应尽早使用粒细胞集落刺激因子。 Objective To observe the effects of G-csf applied in different periods of acute leukemia after chemotherapy.Methods 30 cases in the acute leukemic remission were randomly selected and divided into two groups: control group and treatment group.Then G-csf was applied when the ANC1.0×10~9/L and 48h after chemotherapy respectively until ANC≥1.5×10~9/L.ANC changes and infection rates were observed to evaluate effects of G-csf.Results As for the treatment group,the days of ANC≤0.5×10~9/L lasting,the days reaching ANC≥1.5×10~9/L needed,the days of G-csf used,and the infection rates were all significantly less than the control group(P0.05).The minimum of ANC was obviously higher than the control group(P0.05).Conclusion G-csf should be used early after acute leukemia chemotherapy.
出处 《淮海医药》 CAS 2011年第2期112-113,共2页 Journal of Huaihai Medicine
关键词 粒细胞集落刺激因子 白血病 药物疗法 G-csf Leukemia Chemotherapy
  • 相关文献

参考文献3

二级参考文献22

共引文献22

同被引文献69

  • 1王海山,柴宁.丙种球蛋白在儿科临床的应用[J].辽宁中医杂志,2010,37(S1):187-190. 被引量:4
  • 2申文江,夏廷毅,李宝生,傅小龙,陈龙华.地榆升白片在肿瘤放化疗中的临床应用[J].中国实用内科杂志,2009,29(S1):1-3. 被引量:4
  • 3陈小犊.重组人粒细胞集落刺激因子(rhG—CSF)在急性白血病化疗后应用的疗效观察[J].海峡药学,2006,18(3):136-137. 被引量:1
  • 4孙莉莉,薛学温,王桂云,孙立荣.G-CSF对儿童急性淋巴细胞白血病诱导缓解治疗作用[J].青岛大学医学院学报,2007,43(3):242-243. 被引量:7
  • 5陈力,刘砚韬,尹如铁,张伶俐.肿瘤化疗患者并发败血症的诊治进展[J].中国医院用药评价与分析,2007,7(5):339-341. 被引量:1
  • 6Negrin R, Stein R, Varidiman J, et al. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combina- tion with erythropoietin [J]. Blood, 1993,82( 3 ) :737 - 743.
  • 7Sung L, Nathan PC, Alibhai SM, et al. Meta-analysis: Effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection [ J ] Ann Intern Med,2007,147 (6) :400 - 411.
  • 8Bronchud MH,Potter MR, Morgenstern G, et al. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony stimulating factor in patients [ J]. Br J Cancer, 1988,58 ( 1 ) : 64 - 69.
  • 9Giebel S, Thomas X, Hallbook H, et al. The prophylactic use of granniocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALL [ J ]. Eur J Cancer, 2012,48 (3) : 360 - 367.
  • 10Welte K, Reiter A, Mempel K, et al. A randomized phase- Ill study of the efficacy of granulocyte colonyhttp stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group [ J ]. Blood, 1996,87 ( 8 ) : 3143 - 3150.

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部